These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12176517)

  • 21. Phase III trial of Rapamune versus placebo in primary renal allograft recipients.
    Ponticelli C; MacDonald AS; Rajagopalan P; Sindhi R; Mathew T
    Transplant Proc; 2001 May; 33(3):2271-2. PubMed ID: 11377525
    [No Abstract]   [Full Text] [Related]  

  • 22. Analysis of the factors affecting survival of renal transplant recipients.
    Kim ST; Lee S; Kim JS; Ha J; Chung JK; Kim SJ
    Transplant Proc; 1998 Nov; 30(7):3086-7. PubMed ID: 9838361
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of 160 consecutive living unrelated kidney transplants: 1983-1997.
    Alfani D; Pretagostini R; Rossi M; Poli L; De Simone P; Colonnello M; Novelli G; Urbano D; Venettoni S; Persijn G; Smits J; Cortesini R
    Transplant Proc; 1997 Dec; 29(8):3399-401. PubMed ID: 9414764
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcome of tacrolimus-treated renal transplantation from elderly donors.
    Goto Y; Tanabe K; Tokumoto T; Kondo T; Ishikawa N; Toma H
    Transplant Proc; 2000 Nov; 32(7):1723-5. PubMed ID: 11119908
    [No Abstract]   [Full Text] [Related]  

  • 25. Refining immunosuppressive protocols in pediatric renal transplant recipients.
    Hoyer PF; Vester U
    Transplant Proc; 2001; 33(7-8):3587-9. PubMed ID: 11750524
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term results of spousal renal donor transplants with donor-specific blood transfusions.
    Miura S; Okazaki H; Sato T; Amada N; Ohashi Y; Sato K
    Transplant Proc; 2001; 33(7-8):3417-9. PubMed ID: 11750463
    [No Abstract]   [Full Text] [Related]  

  • 27. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
    Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
    Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term outcomes in pediatric transplantation.
    Fernando ON
    Transplant Proc; 1999 Dec; 31(8):3126-7. PubMed ID: 10616404
    [No Abstract]   [Full Text] [Related]  

  • 29. The excellent results of spousal kidney transplantation: experience in a Japanese single center.
    Sakai K; Okamoto M; Suzuki T; Yoshizawa A; Nobori S; Ushigome H; Sakamoto S; Akioka K; Kaihara S; Yoshimura N
    Transplant Proc; 2008 Sep; 40(7):2118-20. PubMed ID: 18790169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary low-dose tacrolimus immunosuppressive prophylaxis for high-risk kidney transplant recipients.
    Braun F; Lorf T; Grupp C; Schütz E; Sattler B; Canelo R; Müller GA; Ringe B
    Transplant Proc; 1998 Jun; 30(4):1221-3. PubMed ID: 9636496
    [No Abstract]   [Full Text] [Related]  

  • 31. FK 506 in cadaveric kidney transplantation from non-heart-beating donors.
    Hattori R; Ohshima S; Ono Y; Fujita T; Kinukawa T; Matsuura O
    Transplant Proc; 1998 Nov; 30(7):3801-3. PubMed ID: 9838666
    [No Abstract]   [Full Text] [Related]  

  • 32. Cadaveric renal transplantation from non-heart-beating donors with graft survival for more than 10 years.
    Yoshida K; Endo T; Saito T; Ikeda M; Kamata K; Baba S
    Transplant Proc; 2002 Nov; 34(7):2604-7. PubMed ID: 12431541
    [No Abstract]   [Full Text] [Related]  

  • 33. Significance of HLA matching in renal transplantation from living donors.
    Górski A
    Transplant Proc; 1996 Dec; 28(6):3578. PubMed ID: 8962386
    [No Abstract]   [Full Text] [Related]  

  • 34. Early experience using calcineurin-free protocol in recipients of high-risk cadaver renal transplants.
    El-Sabrout R; Delaney V; Butt F; Qadir M; Rashid I; Hanson P; Butt K
    Transplant Proc; 2002 Aug; 34(5):1627-8. PubMed ID: 12176512
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppression in renal transplantation.
    Bonomini V; Scolari MP; Buscaroli A; Liviano D'Arcangelo G; Stefoni S
    Int J Artif Organs; 1997 Feb; 20(2):73-5. PubMed ID: 9093883
    [No Abstract]   [Full Text] [Related]  

  • 36. Omit HLA matching to attain shorter cold ischemic time?
    Aswad S; Mann SL; Khetan U; Asai P; Bogaard T; Mendez RG; Mendez R
    Transplant Proc; 1993 Dec; 25(6):3053-5. PubMed ID: 8266450
    [No Abstract]   [Full Text] [Related]  

  • 37. Complete withdrawal of immunosuppression in kidney allograft recipients: a prospective study in rhesus monkeys.
    Jonker M; van den Hout Y; Neuhaus P; Ringers J; Kuhn EM; Bruijn JA; Schuurman HJ; Noort R; Bontrop RE; Claas FH; van Rood JJ
    Transplant Proc; 1998 Aug; 30(5):2451-3. PubMed ID: 9723534
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of tacrolimus on the outcome of renal transplantation with donor-specific blood transfusion.
    Miura S; Okazaki H; Sato T; Amada N; Ohashi Y
    Transplant Proc; 1998 Jun; 30(4):1212-3. PubMed ID: 9636492
    [No Abstract]   [Full Text] [Related]  

  • 39. Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.
    Birkeland SA
    Transplantation; 2001 Apr; 71(8):1089-90. PubMed ID: 11374407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Graft survival rates in kidney transplant recipients of different blood groups.
    Haberal M; Demirağ A; Moray G; Karakayali H; Akkoç H; Turan M; Bilgin N
    Transplant Proc; 1998 May; 30(3):741-3. PubMed ID: 9595080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.